PMC Articles for MedGen (Select 234775) - PMC

Links from MedGen

Items: 1 to 20 of 166

<< First< Prev

Page of 9

Next >Last >>

Select item 106021741.

Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis

Cristina Fernandez-Valle, Anna Nagel, Julianne Huegel, Alejandra Petrilli, Rosa Rosario, Berta Victoria, Haley Hardin

Version 1. Res Sq. Preprint. 2023 Oct 16. doi: 10.21203/rs.3.rs-3405297/v1

PMCID:: PMC10602174

Article PubReader PDF–3.1M Cite

Select item 105765122.

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients

M J Webb, Bryan J Neth, Lauren M Webb, Jamie J Van Gompel, Michael J Link, Brian A Neff, Matthew L Carlson, Colin L Driscoll, Jim Dornhoffer, Michael W Ruff, Kelsey A Anderson, Sani H Kizilbash, Jian L Campian, Joon H Uhm, Jack I Lane, John C Benson, Daniel J Blezek, Parv M Mehta, Girish Bathla, Ugur T Sener

Neurooncol Adv. 2023 Jan-Dec; 5(1): vdad123. Published online 2023 Sep 22. doi: 10.1093/noajnl/vdad123

PMCID:: PMC10576512

Article PubReader PDF–383K Cite

Select item 104969403.

A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis

Shivani Chiranth, Seppo W Langer, Hans Skovgaard Poulsen, Thomas Urup

Neurooncol Adv. 2023 Jan-Dec; 5(1): vdad099. Published online 2023 Aug 16. doi: 10.1093/noajnl/vdad099

PMCID:: PMC10496940

Article PubReader PDF–453K Cite

Select item 104817814.

The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma

Grace E Gregory, Adam Paul Jones, Michael J Haley, Christopher Hoyle, Leo A H Zeef, I-Hsuan Lin, David J Coope, Andrew T King, D Gareth Evans, Pawel Paszek, Kevin N Couper, David Brough, Omar N Pathmanaban

Brain Commun. 2023; 5(4): fcad197. Published online 2023 Jul 21. doi: 10.1093/braincomms/fcad197

PMCID:: PMC10481781

Article PubReader PDF–1.5M Cite

Select item 103987995.

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma

Scott R Plotkin, Jeffrey Allen, Girish Dhall, Jian L Campian, D Wade Clapp, Michael J Fisher, Rakesh K Jain, James Tonsgard, Nicole J Ullrich, Coretta Thomas, Lloyd J Edwards, Bruce Korf, Roger Packer, Matthias A Karajannis, Jaishri O Blakeley

Neuro Oncol. 2023 Aug; 25(8): 1498–1506. Published online 2023 Apr 3. doi: 10.1093/neuonc/noad066

PMCID:: PMC10398799

Article PubReader PDF–1.4M Cite

Select item 102794136.

Correction to: Vestibular dysfunction in NF2–related schwannomatosis

Brain Commun. 2023; 5(3): fcad179. Published online 2023 Jun 19. doi: 10.1093/braincomms/fcad179

Corrects:: Brain Commun. 2023; 5(2): fcad089.

PMCID:: PMC10279413

Correction PDF–284K Cite

Select item 102438517.

The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis

Grace E Gregory, Abdurrahman I Islim, Cathal John Hannan, Adam P Jones, Charlotte Hammerbeck-Ward, Scott A Rutherford, Simon R Freeman, Simon Lloyd, Michel Kalamarides, Miriam J Smith, Kevin Couper, Catherine A McBain, Michael D Jenkinson, David Brough, Andrew T King, D Gareth Evans, Omar N Pathmanaban

Neurooncol Adv. 2023 May; 5(Suppl 1): i94–i104. Published online 2023 Jun 3. doi: 10.1093/noajnl/vdac127

PMCID:: PMC10243851

Article PubReader PDF–9.1M Cite

Select item 101226458.

Correlation between genotype and phenotype with special attention to hearing in 14 Japanese cases of NF2-related schwannomatosis

Naoki Oishi, Masaru Noguchi, Masato Fujioka, Kiyomitsu Nara, Koichiro Wasano, Hideki Mutai, Rie Kawakita, Ryota Tamura, Kosuke Karatsu, Yukina Morimoto, Masahiro Toda, Hiroyuki Ozawa, Tatsuo Matsunaga

Sci Rep. 2023; 13: 6595. Published online 2023 Apr 22. doi: 10.1038/s41598-023-33812-w

PMCID:: PMC10122645

Article PubReader PDF–1.6M Cite

Select item 100929509.

Spinal Schwannomatosis Mimicking Metastatic Extramedullary Spinal Tumor

Idris Nurdillah, Iqbal Hussain Rizuana, Sharis Osman Syazarina

Diagnostics (Basel) 2023 Apr; 13(7): 1254. Published online 2023 Mar 27. doi: 10.3390/diagnostics13071254

PMCID:: PMC10092950

Article PubReader PDF–1.1M Cite

Select item 1008449910.

Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression

D Gareth Evans, Dorothy Halliday, Rupert Obholzer, Shazia Afridi, Claire Forde, Scott A Rutherford, Charlotte Hammerbeck-Ward, Simon K Lloyd, Simon M Freeman, Omar N Pathmanaban, Owen M Thomas, Roger D Laitt, Stavros Stivaros, John-Paul Kilday, Grace Vassallo, Catherine McBain, Timothy Lavin, Chay Paterson, Gillian Whitfield, Martin G McCabe, Patrick R Axon, Jane Halliday, Samuel Mackeith, Allyson Parry, English Specialist NF2 Research Group , Elaine F Harkness, Juliette Buttimore, Andrew T King

Neurooncol Adv. 2023 Jan-Dec; 5(1): vdad025. Published online 2023 Mar 11. doi: 10.1093/noajnl/vdad025

PMCID:: PMC10084499

Article PubReader PDF–272K Cite

Select item 1007223811.

Vestibular dysfunction in NF2–related schwannomatosis

Amsal S Madhani, Susan King, Jennifer Zhu, Faisal Karmali, D Bradley Welling, Wenli Cai, Justin T Jordan, Richard F Lewis

Brain Commun. 2023; 5(2): fcad089. Published online 2023 Mar 23. doi: 10.1093/braincomms/fcad089

Correction in:: Brain Commun. 2023; 5(3): fcad179.

PMCID:: PMC10072238

Article PubReader PDF–2.0M Cite

Select item 1004706012.

Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series

Jules P. J. Douwes, Kimberley S. Koetsier, Victor S. van Dam, Scott R. Plotkin, Frederick G. Barker, D. Bradley Welling, Jeroen C. Jansen, Erik F. Hensen, Helen A. Shih

Curr Oncol. 2023 Mar; 30(3): 3473–3483. Published online 2023 Mar 20. doi: 10.3390/curroncol30030263

PMCID:: PMC10047060

Article PubReader PDF–573K Cite

Select item 993451913.

Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain

Zhenzhen Yin, Limeng Wu, Yanling Zhang, Yao Sun, John W. Chen, Sonu Subudhi, William Ho, Grace Y. Lee, Athena Wang, Xing Gao, Jun Ren, Chao Zhu, Na Zhang, Gino B. Ferraro, Alona Muzikansky, Luo Zhang, Anat Stemmer-Rachamimov, Jianren Mao, Scott R. Plotkin, Lei Xu

Version 1. bioRxiv. Preprint. 2023 Feb 6. doi: 10.1101/2023.02.06.527377

PMCID:: PMC9934519

Article PubReader Cite

Select item 969623114.

A Rare Case of Familial Schwannomatosis Showing Intrafamilial Variability with Identification of a Shared Novel Germline SMARCB1 Mutation

Jun Hyun Lee, Jae Seok Jeong, Kum Ju Chae, Yeon-Hee Han, So Ri Kim, Yong Chul Lee

Medicina (Kaunas) 2022 Nov; 58(11): 1592. Published online 2022 Nov 3. doi: 10.3390/medicina58111592

PMCID:: PMC9696231

Article PubReader PDF–1.3M Cite

Select item 967867415.

Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro

Núria Catasús, Inma Rosas, Sandra Bonache, Alex Negro, Miguel Torres-Martin, Adrià Plana-Pla, Hector Salvador, Eduard Serra, Ignacio Blanco, Elisabeth Castellanos, NF2-related SWN Spanish National Reference Centre HUGTP-ICO-IGTP

Mol Ther Nucleic Acids. 2022 Dec 13; 30: 493–505. Published online 2022 Nov 4. doi: 10.1016/j.omtn.2022.10.026

PMCID:: PMC9678674

Article PubReader PDF–3.0M Cite

Select item 957918316.

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

Jineta Banerjee, Jan M. Friedman, Laura J. Klesse, Kaleb H. Yohay, Justin T. Jordan, Scott R. Plotkin, Robert J. Allaway, Jaishri O. Blakeley

Genet Med. 2023 Feb; 25(2): 100324. Published online 2022 Oct 19. doi: 10.1016/j.gim.2022.10.007

PMCID:: PMC9579183

Article PubReader PDF–882K Cite

Select item 954047217.

Screening of potential novel candidate genes in schwannomatosis patients

Cristina Perez‐Becerril, Andrew J. Wallace, Helene Schlecht, Naomi L. Bowers, Philip T. Smith, Carolyn Gokhale, Helen Eaton, Chris Charlton, Rachel Robinson, Ruth S. Charlton, D. Gareth Evans, Miriam J. Smith

Hum Mutat. 2022 Oct; 43(10): 1368–1376. Published online 2022 Jun 27. doi: 10.1002/humu.24424

PMCID:: PMC9540472

Article PubReader PDF–1.0M Cite

Select item 942416918.

Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization

Isabel Gugel, Florian Grimm, Marcos Tatagiba, Martin U. Schuhmann, Julian Zipfel

J Neurooncol. 2022; 159(2): 271–279. Published online 2022 Jun 30. doi: 10.1007/s11060-022-04061-0

PMCID:: PMC9424169

Article PubReader PDF–952K Cite

Select item 938117719.

A Linear Variant of Segmental Schwannomatosis Localized to the Upper Extremity

Ashkaun Shaterian, Tuna Ozyurekoglu

J Hand Microsurg. 2022 Apr; 14(2): 160–162. Published online 2020 Sep 22. doi: 10.1055/s-0040-1715424

PMCID:: PMC9381177

Article PubReader PDF–3.9M Cite

Select item 937858720.

Understanding Barriers to Diagnosis in a Rare, Genetic Disease: Delays and Errors in Diagnosing Schwannomatosis

Vanessa L. Merker, Bronwyn Slobogean, Justin T. Jordan, Shannon Langmead, Mark Meterko, Martin P. Charns, A. Rani Elwy, Jaishri O. Blakeley, Scott R. Plotkin

Am J Med Genet A. Author manuscript; available in PMC 2023 Sep 1.

Published in final edited form as: Am J Med Genet A. 2022 Sep; 188(9): 2672–2683. Published online 2022 Jun 9. doi: 10.1002/ajmg.a.62860

PMCID:: PMC9378587

Article PubReader PDF–616K Cite

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 166

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity